The costs of acromegaly management in Poland — analysis from one centre
Treatment with somatostatin analogues is the major cost factor in patients requiring chronic therapy. Effective radical neurosurgical treatment reduces the incidence of chronic complications of acromegaly and lowers the overall treatment costs.
Authors
- Michał Elbaum
- Marcin Kałużny (ORCID: https://orcid.org/0000-0002-8782-0778)
- Agnieszka Zembska
- Aleksandra Jawiarczyk-Przybyłowska (ORCID: https://orcid.org/0000-0003-0432-905X)
- Beata Wojtczak (ORCID: https://orcid.org/0000-0002-9953-0460)
- Marek Bolanowski (ORCID: https://orcid.org/0000-0002-2360-6596)
Institutions
- Wroclaw Medical University (PL)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2025-02-26
- DOI
- https://doi.org/10.5603/ep.103200
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ipsen